|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Outcome of up- front combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma 显示文摘 | RENI M CEREDA S BALZANO G | 2009 | Cancer Chemother Pharmacol2009，64，6： | 1 |
| 2 | PEFG (Cisplatin,epirubicin,5-fluorouracil,gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy显示文摘 | Reni M Cereda S Masza E | 2008 | American J Clin Oncol2008，31，2： | 1 |
| 3 | A randomized phase Ⅱtrial of two different four-drug combinations in advanced pancreatic adenocarcinoma:Cisplatin,capecimbine,gemcitabine plus either epirubicin or docetaxel显示文摘 | Cereda S Rognone A Ghidini M | 2009 | J Clin Oncol2009，27，： | 1 |
| 4 | A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epiru- bicin or docetaxel (PEXG or PDXG regimen)显示文摘 | Reni M Cereda S Rognone A | 2012 | Cancer Chemother Pharmacol2012，69，1： | 1 |
| 5 | First Principles Study of GeSi Exchange Mechanisms at the Si(100)of Surface显示文摘 | Zipoli F Cereda S Ceriotti M | | 0，，19： | 1 |
| 6 | Phase Ⅳ trial of dose-in-tense PEFG ( cisplatin, epirubicin, 5-fluomuracil, gemcitabine)in advanced pancreatic adenocarcinoma 显示文摘 | Reni M Cereda S Passoni P | 2006 | Proc Am Soc ClinOncol2006，24，： | 1 |
| 7 | Adjuvant PEFG (cisplatin,epirubicin,5-fluorouracil,gemcitabine) or gemcitabine in pancreatic cancer:a randomized phase II trial显示文摘 | Reni M Cereda S Aprile G | 2009 | European Journal of Cancer Supplements2009，7，2： | 1 |
| 8 | Outcome of upfront combi- nation chemotherapy followed by chemoradiation for locally ad- vanced pancreatic adenocarcinoma 显示文摘 | Reni M Cereda S Balzano G | 2009 | Cancer Chemother Phar- macol2009，64，6： | 1 |
| 9 | Neoadjuvant therapy in resectable pancreatic cancer:a critical review显示文摘 | Belli C Cereda S Anand S | 2013 | Cancer Treat Rev2013，39，5： | 1 |
| 10 | In vitro degradation of linamarin by microorganisms isolated from cassava wastewater treatment lagoons显示文摘 | VASCONCELLOS S P CEREDA M P CAGNON J R | 2009 | Brazilian Journal of Microbiology2009，40，： | 1 |
| 11 | Maintenance sunitinib or ob- servation in metastatic pancreatic adenocarcinoma: a phase II ran- domised trial显示文摘 | Reni M Cereda S Milella M | 2013 | Eur J Cancer2013，49，17： | 1 |
| 12 | A randomized phase Ⅱ trial of two different 4-drug combinations in advanced pancreatic adenocar- cinoma:cisplatin,capecitabiue,gemcitabine plus either epirubicin or doeetaxel (PEXG or PDXG regimen)显示文摘 | Reni M Cereda S Rognone A | 2012 | Cancer Chemother Pharma- col2012，1，69： | 1 |
| 13 | Evaluation of the in vitro activity of cefprozil relative to other oral antimicrobialagents against bacteria in clinical specimens from patients in Sao Paulo with respiratorytract infections 显示文摘 | Sader H S Cereda R Oplustil C etal | 1998 | Braz J Infect Dis1998，2，： | 1 |
| 14 | PEFG ( Cisplatin, epirubicin, 5-fluorouracil, gemcitabine )regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing ehemotherspy 显示文摘 | Reni M Cereda S Mazza E | 2008 | American J Clin Oncol2008，31，2： | 1 |
| 15 | A randomized phase II trial of two different four drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcit- abine plus either epirubicin or docetaxel显示文摘 | Cereda S Rognone A Ghidini M | 2009 | J Clin Oncol2009，27，10： | 1 |
| 16 | Maintenance sunitinibor observation in metastatic pancreatic adenocarcinoma: aphase I randomised trial 显示文摘 | RENI M CEREDA S MILELLA M | 2013 | Eur J Cancer2013，49，17： | 1 |
| 17 | Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyees cerevisiae) vector encoding carcinoembryonic antigen显示文摘 | Remondo C Cereda V Mostb6ck S | 2009 | Vaccine2009，27，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员